Literature DB >> 12438837

Training primary health care professionals to provide buprenorphine and LAAM treatment.

Nicholas Lintzeris1, Alison Ritter, Adrian Dunlop, Peter Muhleisen.   

Abstract

This paper describes the development and implementation of training programs for primary care medical practitioners and pharmacists in the delivery of buprenorphine and LAAM treatment in the management of opiate dependence. Separate training programs were developed for each medication. Each training package included learning objectives, training materials, and assessment instruments. Findings of the evaluation of these initiatives and the subsequent Australian postregistration training program for buprenorphine are described.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12438837     DOI: 10.1080/08897070209511497

Source DB:  PubMed          Journal:  Subst Abus        ISSN: 0889-7077            Impact factor:   3.716


  7 in total

1.  Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine.

Authors:  Annemarie Unger; Erika Jung; Bernadette Winklbaur; Gabriele Fischer
Journal:  J Addict Dis       Date:  2010-04

2.  Evaluation of a combined online and in person training in the use of buprenorphine.

Authors:  Erik W Gunderson; David A Fiellin; Frances R Levin; Lynn E Sullivan; Herbert D Kleber
Journal:  Subst Abus       Date:  2006-09       Impact factor: 3.716

Review 3.  Buprenorphine: new treatment of opioid addiction in primary care.

Authors:  Meldon Kahan; Anita Srivastava; Alice Ordean; Sharon Cirone
Journal:  Can Fam Physician       Date:  2011-03       Impact factor: 3.275

4.  Buprenorphine for opioid dependence.

Authors:  Walter Ling
Journal:  Expert Rev Neurother       Date:  2009-05       Impact factor: 4.618

Review 5.  Treatment of opioid-dependent pregnant women: clinical and research issues.

Authors:  Hendree E Jones; Peter R Martin; Sarah H Heil; Karol Kaltenbach; Peter Selby; Mara G Coyle; Susan M Stine; Kevin E O'Grady; Amelia M Arria; Gabriele Fischer
Journal:  J Subst Abuse Treat       Date:  2008-01-14

6.  The Role of Medicinal Cannabis in Clinical Therapy: Pharmacists' Perspectives.

Authors:  Sami Isaac; Bandana Saini; Betty B Chaar
Journal:  PLoS One       Date:  2016-05-12       Impact factor: 3.240

Review 7.  Practical considerations for the clinical use of buprenorphine.

Authors:  Hendree E Jones
Journal:  Sci Pract Perspect       Date:  2004-08
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.